Company Filing History:
1 out of 647 
1 out of 1 Years Active: 2002-2003
Title: Innovations and Contributions of Jeffrey Kudlow
Introduction
Jeffrey Kudlow is an accomplished inventor based in Birmingham, AL (US). He has made significant contributions to the field of diabetes research through his innovative patents. With a total of 2 patents, Kudlow's work focuses on methods to improve pancreatic health and the treatment of diabetes.
Latest Patents
Kudlow's latest patents include a method for inhibiting pancreatic β-cell O-glycosylation. This invention demonstrates a method for inhibiting O-linked protein glycosylation in a tissue or cell. The process involves contacting the tissue or cell with (Z)-1-[N-(3-Ammoniopropyl)-N-(n-propyl)amino] diazen-ium-1,2-diolate or a derivative thereof. Additionally, this patent outlines a method for treating or inhibiting the onset of diabetes mellitus by administering a pharmacological dose of a compound that inhibits O-linked protein glycosylation. Furthermore, it provides a pharmaceutical composition that includes (Z)-1-[N-(3-Ammoniopropyl)-N-(n-propyl)amino] diazen-ium-1,2-diolate and a pharmaceutically acceptable carrier.
Another notable patent addresses the protection of pancreatic β-cells during islet isolation and the assessment of islet viability and candidate diabetes drugs. This invention highlights that standard pancreatic islet isolation can lead to β-cell toxicity due to nitric oxide and/or streptozotocin-like molecules generated during the process. Kudlow's work suggests that this toxicity can be limited by adding compounds that work through the glucosamine pathway in islets or by using nitric oxide inhibitors.
Career Highlights
Throughout his career, Jeffrey Kudlow has worked with reputable organizations such as the UAB Research Foundation and Nab Research Foundation. His research has significantly advanced the understanding of diabetes and the protection of pancreatic cells.
Collaborations
Kudlow has collaborated with various professionals in his field, including Robert John Konrad. Their joint efforts have contributed to the development of innovative solutions for diabetes treatment.
Conclusion
Jeffrey Kudlow's contributions to diabetes research through his patents and collaborations have made a lasting impact in the field. His innovative methods for protecting pancreatic β-cells and treating diabetes continue to inspire further research and development.